Unterschiedliche Beeinflußbarkeit der Noradrenalin- und Isoprenalinwirkungen am isolierten Meerschweinchenvorhof
Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie - Tập 256 - Trang 207-217 - 1967
Tóm tắt
The actions of noradrenaline and isoprenaline on isolated guinea pig atria have been analyzed by a study of the modification by various drugs of the responses to these catechol amines. Drugs used were cocaine, reserpine, phenoxybenzamine, guanethidine, tyramine, hexamethonium and nialamide. While pretreatment with reserpine or nialamide had no detectable influence on the responses of the atria to catechol amines, the exposure of normal atria or of atria obtained from reserpine-treated animals to cocaine, guanethidine, phenoxybenzamine and tyramine resulted in potentiation of the responses to noradrenaline and subsensitivity to isoprenaline; hexamethonium was without influence on the responses to both catechol amines. The antagonism between cocaine and isoprenaline had, for the concentrations studied, the character of a competitive one, cocaine causing a parallel shift of the dose-response curve to the right; as was expected, the same concentrations of cocaine potentiated noradrenaline, shifting the dose-response curve to the left. Although in opposite senses, cocaine shifted the curves roughly by the same distance. In higher concentrations, cocaine depressed also the responses to noradrenaline; when added to the bath during the action of noradrenaline or isoprenaline, cocaine induced a faster termination of the stimulant effects of the catechol amines. Cocaine somewhat antagonized the responses of the atria to histamine, but not in the same degree as those to isoprenaline. The results are discussed in the light of present knowledge about the mechanism of supersensitivity to noradrenaline due to cocaine. It is concluded that it is not mandatory to accept two different sets of cardiac β-receptors (one activated by noradrenaline, another by isoprenaline) in order to explain the results obtained. Cocaine probably influences in two ways the cardiac actions of catechol amines, preventing their uptake by tissues and antagonizing their actions at the level of the receptors, the first action resulting in an increase of the concentration of the agonist drug. The overall effect should be supersensitivity to amines whose action is predominantly terminated by uptake (like noradrenaline) and subsensitivity to amines which are not, or only in a minor degree, taken up by tissues (like isoprenaline); higher concentrations of cocaine should be able to reduce the responses to all amines. This working hypothesis agrees fairly well with the referred results.
Tài liệu tham khảo
Benfey, B. G.: Cardiovascular actions of phenoxybenzamine. Brit. J. Pharmacol. 16, 6–14 (1961).
——, and K. Greeff: Interactions of sympathomimetic drugs and their antagonists on the isolated atrium. Brit. J. Pharmacol. 17, 232–235 (1961).
Blinks, J. R.: The nature of the antagonism by methoxamine of the chronotropic and inotropic effects of catecholamines. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 248, 73–84 (1964).
Cervoni, P., S. M. Kirpekar, and A. Schwab: The effect of drugs on uptake and release of catecholamines in the isolated left atrium of the guinea pig. J. Pharmacol. exp. Ther. 151, 196–206 (1966).
Costa, E., D. J. Boullin, W. Hammer, W. Vogel, and B. B. Brodie: Modification of sympathetic function. E. Interactions of drugs with adrenergic neurons. Pharmacol. Rev. 18, 577–597 (1966).
Crout, J. R.: Enhancement of the chronotropic action of norepinephrine by tyramine. Pharmacologist 5, 257 (1963).
Deripe, D. R. van, and N. C. Moran: Comparison of cardiac and vasodilator adrenergic blocking activity of DCI and four analogs. Fed. Proc. 24, 712 (1965).
Furchgott, R. F.: Modification of sympathetic function. J. Summary of discussion and commentary. Pharmacol. Rev. 18, 641–644 (1966).
——, and A. Schwab: Actions and interactions of norepinephrine, tyramine and cocaine on aortic strips of rabbit and left atria of guinea pig and cat. J. Pharmacol. exp. Ther. 142, 39–58 (1963).
Garrett, J., and C. Sousa: Effects of guanethidine on smooth muscles. Arzneimittel-Forsch. 13, 125–130 (1963).
Greeff, K., B. G. Benfey u. A. Bokelmann: Anaphylaktische Reaktionen am isolierten Herzvorhofpräparat des Meerschweinchens und ihre Beeinflussung durch Antihistaminica, BOL, Dihydroergotamin und Reserpin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 236, 421–434 (1959).
Hertting, G.: The fate of H3-Isoproterenol in the rat. Biochem. Pharmacol. 13, 1119–1128 (1964).
Holtz, P., W. Osswald u. K. Stock: Über die Beeinflussung der Wirkungen sympathicomimetischer Amine durch Cocain und Reserpin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 239, 14–28 (1960).
——, u. E. Westermann: Versuche mit Acetyl-, Propionyl-und Butyrylcholin am isolierten Herzvorhofpräparat. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 225, 421–427 (1955).
Lee, W. C., Y. H. Shin, and F. E. Shideman: Cardiac activities of several monoamine oxidase inhibitors. J. Pharmacol. exp. Ther. 133, 180–185 (1961).
Levy, B.: The adrenergic blocking activity of N-tert-butylmethoxamine (butoxamine). J. Pharmacol. exp. Ther. 151, 413–422 (1966).
Lindmar, R., u. E. Muscholl: Die Verstärkung der Noradrenalinwirkung durch Tyramin. Naunyn-Schmiedebergs Arch.exp.Path.Pharmak. 252, 122–133 (1965).
Mannaioni, P. F.: Interaction between histamine and dichloroisoproterenol, hexamethonium, pempidine, and diphenhydramine, in normal and reserpinetreated heart preparations. Brit. J. Pharmacol. 15, 500–505 (1960).
Osswald, W., u. S. Guimarães: Über den Mechanismus der Isopropylnoradrenalinumkehr. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 243, 1–15 (1962).
Shanks, R. G.: Methods for the evaluation of adrenergic beta-receptor antagonists. Methods in drug evaluation (p. 183). Ed. P. Mantegazza, and F. Piccinini. Amsterdam: North-Holland Publishing Comp. 1966.
Stafford, A.: Potentiation of some catechol amines by phenoxybenzamine, guanethidine and cocaine. Brit. J. Pharmacol. 21, 361–367 (1963).
Trendelenburg, U.: The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J. Pharmacol. exp. Ther. 130, 450–460 (1960).
—— Modification of sympathetic function. I. Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev. 18, 629–640 (1966).